These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Corticosteroid therapy for critically ill patients with COVID-19: A structured summary of a study protocol for a prospective meta-analysis of randomized trials. Sterne JAC; Diaz J; Villar J; Murthy S; Slutsky AS; Perner A; Jüni P; Angus DC; Annane D; Azevedo LCP; Du B; Dequin PF; Gordon AC; Green C; Higgins JPT; Horby P; Landray MJ; Lapadula G; Le Gouge A; Leclerc M; Savović J; Tomazini B; Venkatesh B; Webb S; Marshall JC; Trials; 2020 Aug; 21(1):734. PubMed ID: 32831155 [TBL] [Abstract][Full Text] [Related]
5. Systemic corticosteroids for the treatment of COVID-19. Wagner C; Griesel M; Mikolajewska A; Mueller A; Nothacker M; Kley K; Metzendorf MI; Fischer AL; Kopp M; Stegemann M; Skoetz N; Fichtner F Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014963. PubMed ID: 34396514 [TBL] [Abstract][Full Text] [Related]
6. Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial. Busani S; Tosi M; Mighali P; Vandelli P; D'Amico R; Marietta M; Forfori F; Donati A; Cinnella G; De Monte A; Pasero D; Bellani G; Tascini C; Foti G; Ranieri M; Girardis M Trials; 2020 Aug; 21(1):724. PubMed ID: 32807241 [TBL] [Abstract][Full Text] [Related]
7. Potential therapeutic use of corticosteroids as SARS CoV-2 main protease inhibitors: a computational study. Ghosh R; Chakraborty A; Biswas A; Chowdhuri S J Biomol Struct Dyn; 2022 Mar; 40(5):2053-2066. PubMed ID: 33094701 [TBL] [Abstract][Full Text] [Related]
8. Systemic corticosteroids for management of COVID-19: Saving lives or causing harm? FakhriRavari A; Jin S; Kachouei FH; Le D; Lopez M Int J Immunopathol Pharmacol; 2021; 35():20587384211063976. PubMed ID: 34923856 [TBL] [Abstract][Full Text] [Related]
9. Comparison of pulse-dose and high-dose corticosteroids with no corticosteroid treatment for COVID-19 pneumonia in the intensive care unit. Yaqoob H; Greenberg D; Hwang F; Lee C; Vernik D; Manglani R; Wang Z; Murad MH; Chandy D; Epelbaum O J Med Virol; 2022 Jan; 94(1):349-356. PubMed ID: 34542192 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of corticosteroid in patients with COVID-19: A multi-center retrospective study and meta-analysis. Zhan Y; Shang J; Gu Y; Huang Q; Xie J J Med Virol; 2021 Jul; 93(7):4292-4302. PubMed ID: 33666250 [TBL] [Abstract][Full Text] [Related]
11. Corticosteroids in SARS-COV2 infection: certainties and uncertainties in clinical practice. Crisan Dabija R; Antohe I; Trofor A; Antoniu SA Expert Rev Anti Infect Ther; 2021 Dec; 19(12):1553-1562. PubMed ID: 34015985 [TBL] [Abstract][Full Text] [Related]
12. Corticosteroids in critical COVID-19: Are all corticosteroids equal? Du Plessis EM; Lalla U; Allwood BW; Louw EH; Nortje A; Parker A; Taljaard JJ; Ayele BT; Nyasulu PS; Koegelenberg CFN S Afr Med J; 2021 Apr; 111(6):550-553. PubMed ID: 34382564 [TBL] [Abstract][Full Text] [Related]
13. Clinical Use of Short-Course and Low-Dose Corticosteroids in Patients With Non-severe COVID-19 During Pneumonia Progression. Hu Z; Lv Y; Xu C; Sun W; Chen W; Peng Z; Chen C; Cui X; Jiao D; Cheng C; Chi Y; Wei H; Hu C; Zeng Y; Zhang X; Yi Y Front Public Health; 2020; 8():355. PubMed ID: 32719766 [No Abstract] [Full Text] [Related]
14. Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis. Li H; Chen C; Hu F; Wang J; Zhao Q; Gale RP; Liang Y Leukemia; 2020 Jun; 34(6):1503-1511. PubMed ID: 32372026 [TBL] [Abstract][Full Text] [Related]
15. Association between different corticosteroid regimens used in severe SARS-CoV-2 infection and short-term mortality: retrospective cohort study. González-Castro A; Fernandez A; Cuenca-Fito E; Peñasco Y; Ceña J; Rodríguez Borregán JC Rev Esp Anestesiol Reanim (Engl Ed); 2024 May; 71(5):379-386. PubMed ID: 38395302 [TBL] [Abstract][Full Text] [Related]
16. Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a mechanistic analysis. Baker JR; Mahdi M; Nicolau DV; Ramakrishnan S; Barnes PJ; Simpson JL; Cass SP; Russell REK; Donnelly LE; Bafadhel M Lancet Respir Med; 2022 Jun; 10(6):545-556. PubMed ID: 35397798 [TBL] [Abstract][Full Text] [Related]
17. Inhaled corticosteroids for the treatment of COVID-19. Griesel M; Wagner C; Mikolajewska A; Stegemann M; Fichtner F; Metzendorf MI; Nair AA; Daniel J; Fischer AL; Skoetz N Cochrane Database Syst Rev; 2022 Mar; 3(3):CD015125. PubMed ID: 35262185 [TBL] [Abstract][Full Text] [Related]
18. Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection. Ye ZW; Yuan S; Chan JF; Zhang AJ; Yu CY; Ong CP; Yang D; Chan CC; Tang K; Cao J; Poon VK; Chan CC; Cai JP; Chu H; Yuen KY; Jin DY Emerg Microbes Infect; 2021 Dec; 10(1):291-304. PubMed ID: 33538646 [TBL] [Abstract][Full Text] [Related]
19. A Comparison of the Efficacy of Adjuvant Parenteral Methylprednisolone and Dexamethasone in Reducing Covid-19 Disease Severity and Mortality among the Moderate to Critical Patients -A Retrospective Study. Krishnaswamy P; Bs N; Hegde SV J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443522 [TBL] [Abstract][Full Text] [Related]
20. Corticosteroids for COVID-19: worth it or not? Akter F; Araf Y; Hosen MJ Mol Biol Rep; 2022 Jan; 49(1):567-576. PubMed ID: 34643927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]